Complete versus culprit-vessel only revascularization in STEMI: An updated meta-analysis of randomized control trials☆

• Kartik Gupta,
• Lakshay Chopra,
• Ameen Salame,
• Nitin Gharpure,
• Shane P. Prejean,
• Gregory von Mering,
• Firas Al Solaiman,
• Kyle Eudailey,
• Navkaranbir S. Bajaj,
• Mustafa I. Ahmed

Affiliations

Kartik Gupta

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA

Lakshay Chopra

All India Institute of Medical Sciences, New Delhi, India

Ameen Salame

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA

Nitin Gharpure

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA

Shane P. Prejean

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA

Gregory von Mering

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA

Firas Al Solaiman

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA

Kyle Eudailey

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA

Navkaranbir S. Bajaj

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA; Section of Cardiology, Birmingham Veterans Affair Medical Center, Birmingham, AL, USA; Division of Molecular Imaging and Therapeutics, Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA

Mustafa I. Ahmed

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA; Corresponding author at: Associate Professor and Director, Structural Heart Program, Division of Cardiovascular Disease, The University of Alabama at Birmingham, 619 19th Street South, Birmingham 35233, AL, USA.